DISPHANURAT, W. .; SRISANTITHUM, B. . Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A randomized Evaluator-blind Trial. Asian Medical Journal and Alternative Medicine, [S. l.], v. 22, n. -, p. S117, 2022. DOI: 10.14456/2022s10724. Disponível em: https://asianmedjam.com/index.php/amjam/article/view/1287. Acesso em: 19 apr. 2024.